Pyxis Oncology IPO

Pyxis Oncology builds a differentiated portfolio of biologics, including antibody-drug conjugates and immunotherapies, to improve the lives of patients with difficult-to-treat cancers.

Register for Details

For more details on financing and valuation for Pyxis Oncology, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Pyxis Oncology Ticker Symbol


Pyxis Oncology Stock Price

$1.29 as of 12/5/22